Medical Dermatology Career Development Award

Christina Kraus, MD
University California, Irvine
Developing Metrics for Disease Burden and Identification of Biomarkers in Vulvar Lichen Sclerosus

Lauren Madigan, MD
University of Utah
Developing Better Understanding of Adult-Onset Mastocytosis in the Skin

Helena Pasieka, MD, MS
Uniformed Services University
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Improving Clinical Assessment, Pedric

Bridget Shields, MD
University of Wisconsin
Elucidating the LCinical and Molecular Immunometabolic Microenvironment of Granuloma Annulare

Emily L. Baumrin, MD - Year 2
University of Pennsylvania Hospital
Chronic Graft-versus-host-Disease: Development of a Skin-specific Patient-reported Outcome Measure

Brittany L. Dulmage, MD - Year 2
Ohio State University Medical Center
The Impact, Disparities, and Assessment Methods of Alopecia in Cancer Patients

Yevgeniy R. Semenov, MD, MA - Year 2
Massachusetts General Hospital
Epidemiologic and Genetic Risk Factors for Cutaneous Immunotherapy Toxicities

Tina Bhutani, MD, MAS - Year 3
University of California, San Francisco
Evaluating the Impact of Sleep on Psoriasis and Associated Comorbidities

Steven T. Chen, MD, MPH, MS-HPEd - Year 3
Massachusetts General Hospital
Investigation of Dermatologic Toxicity from Immune Checkpoint Blockade in Advanced Malignancies

Galen T. Foulke, MD - Year 3
Penn State Milton S. Hershey Med Center
Closing Practice Gaps in Dermatomyositis Malignancy Screening

Emily L. Baumrin, MD
University of Pennsylvania Hospital
Chronic Graft-versus-Host Disease: Development of a Skin-specific Patientreported Outcome Measure

Brittany L. Dulmage, MD
Ohio State University Medical Center
The Impact, Disparities, and Assessment Methods of Alopecia in Cancer Patients

Galen T. Foulke, MD
University of North Carolina, Chapel Hill
Closing Practice Gaps in Dermatomyositis Malignancy Screening

Yevgeniy R. Semenov, MD, MA
Massachusetts General Hospital
Epidemiologic and Genetic Risk Factors for Cutaneous Immunotherapy Toxicities

Tina Bhutani, MD - Year 2
University of California, San Francisco 
Evaluating the Impact of Sleep on Psoriasis and Associated Comorbidities 

Steven T. Chen, MD, MPH - Year 2
Massachusetts General Hospital 
Investigation of Dermatologic Toxicity from Immune Checkpoint Blockade in Advanced Malignancies

Crystal U. Aguh, MD – Year 3
Johns Hopkins University 
Exploring Gene Expression Patterns and Biomarkers of Disease Severity in CCCA 

Tina Bhutani, MD
University of California, San Francisco 
Evaluating the Impact of Sleep on Psoriasis and Associated Comorbidities 

Steven T. Chen, MD, MPH 
Massachusetts General Hospital 
Investigation of Dermatologic Toxicity from Immune Checkpoint Blockade in Advanced Malignancies 

Galen T. Foulke, MD
University of North Carolina, Chapel Hill 
Closing Practice Gaps in Dermatomyositis Malignancy Screening 

Crystal U. Aguh, MD – Year 2 
Johns Hopkins University 
Exploring Gene Expression Patterns and Biomarkers of Disease Severity in CCCA 

Albert Chiou, MD – Year 3 
Stanford University 
Evaluating Collagen VII Corrected Skin Grafts for Recessive Dystrophic Epidermolysis Bullosa 

Shawn G. Kwatra, MD – Year 3 
Johns Hopkins University 
Racial Differences in Biomarkers and Therapeutic Targets for Chronic Itch 

Crystal U. Aguh, MD
Johns Hopkins University
Exploring Gene Expression Patterns & Biomarkers of Disease Severity in CCCA

Albert Chiou, MD – Year 2
Stanford University
Evaluating Collagen VII Corrected Skin Grafts for Recessive Dystrophic Epidermolysis Bullosa

Benjamin H. Kaffenberger, MD – Year 3
Ohio State University
Prospective Categorization and Outcomes Analysis of Cutaneous Drug Eruptions

Shawn G. Kwatra, MD – Year 2
Johns Hopkins University
Racial Differences in Biomarkers and Therapeutic Targets for Chronic Itch

Cecilia Larocca, MD – Year 3
Brigham and Women's Hospital
An Implantable Microdevice for Candidate in Situ Drug Sensitivity Testing in Myocosis Fungoides

Xiaolong Zhou, MD, MSc – Year 3
Northwestern University
Characterization of the Skin Microbiome in Cutaneous T Cell Lymphoma

Zelma C. Chiesa-Fuxench, MD – Year 3
University of Pennsylvania Hospital
Atopic Dermatitis: Expanding Our Understanding of Complex Disease in the Hispanic Population

Albert Chiou, MD
Stanford Univ. School of Medicine
Collagen VII Corrected Skin Grafts for Recessive Dystrophic Epidermolysis Bullosa

Benjamin H. Kaffenberger, MD – Year 2
Ohio State University Medical Center
Prospective Categorization and Outcome Analysis of Cutaneous Drug Eruptions

Shawn G. Kwatra, MD
Johns Hopkins Medical Institutions
Racial Differences in Biomarkers and Therapeutic Targets for Chronic Itch

Cecilia Larocca, MD – Year 2
Brigham and Women's Hospital
An Implantable Microdevice for Candidate in Situ Drug Sensitivity Testing in Mycosis Fungoides

Hadar Lev-Tov, MD, MAS – Year 3
University of Miami
Understanding First Venous Leg Ulcers in People with Venous Insufficiency

Alina Markova, MD – Year 3
Cornell University
Epidemiology and Mechanisms of Dermatologic Disease in Hospitalized Patients with Cancer

Xiaolong Zhou, MD, MSc – Year 2
Northwestern University
Characterization of the Skin Microbiome in Cutaneous T Cell Lymphoma